22x Fund (22x)

Invest in the Best Silicon Valley Startups

Review Score
2.62/5
ICO Price
1 USD
Pre ICO Price
0.85 USD
Soft Cap
10,000,000 USD
Hard Cap
35,000,000 USD
Pre ICO Start Date
26 January 2018
Pre ICO End Date
9 March 2018
Start Date
9 March 2018
End Date
23 March 2018

What is 22x Fund?

https://youtu.be/zLMbKYGIVSo

2X Ltd. is issuing tokens  that provide qualified investor exposure to equity in up to 30 Silicon Valley startups, that are all alumni of the 500 Startups Global Seed Accelerator program. In connection with this issuance, 22X is seeking to turn venture capital on its head by pre-selecting a diverse group of companies that are expected to be fast- growth, and providing investors with an opportunity to indirectly invest in these companies without paying the high minimums and large fees associated with venture capital investment, by purchasing 22X Tokens.

Open Website Open Whitepaper

Rating

Average Rating 52.50%
ICO Bench 44%
ICO Marks 61%

General Info

Symbol 22x
Category Investment, Other, Platform
Pre ICO Start Date 26 January 2018
Pre ICO End Date 9 March 2018
Start Date 9 March 2018
End Date 23 March 2018
Bonus Not Available
Bounty Not Available
Platform Ethereum
Accepting BTC, ETH, Fiat

Investment Info

PreICO Price 1 22x = 0.85 USD
ICO Price 1 22x = 1 USD

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of CoinCheckup.com and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on CoinCheckup.com and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on CoinCheckup.com and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.